What does WEZEFARMA do?

WEZEFARMA is a pharmacy in Rotselaar. Private Limited, started on 1 September 1999, 1 establishment.

What is the address of WEZEFARMA?

The registered office of WEZEFARMA is located at Aarschotsesteenweg 154 box 0.02, 3111 Rotselaar.

Is WEZEFARMA still active?

Yes. According to the CBE (30 October 2026) WEZEFARMA is active, legal situation “Normale toestand”, started on 1 September 1999.

Is WEZEFARMA registered on Peppol?

Yes, WEZEFARMA is registered on the Peppol network with ID 0208:0466775480.

What is the enterprise number of WEZEFARMA?

The enterprise number of WEZEFARMA is BE0466775480.

When was WEZEFARMA founded?

WEZEFARMA was founded on 1 September 1999.

Who are the directors of WEZEFARMA?

According to the 2025 annual accounts, the directors of WEZEFARMA are: PASSIFLORA.

Is WEZEFARMA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 September 1999; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did WEZEFARMA make in 2025?

WEZEFARMA posted a profit after taxes of € 186,315 in financial year 2025.

What is the revenue of WEZEFARMA?

As a small company, WEZEFARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 401,976.

How much does an employee at WEZEFARMA earn?

The average wage cost per full-time employee at WEZEFARMA was € 76,700 in 2025: staff costs of € 153,322 for 2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does WEZEFARMA have?

According to the 2025 annual accounts, WEZEFARMA has 2 full-time equivalents (FTE).

Does WEZEFARMA have a website?

Yes, WEZEFARMA has a website at wezefarma.be.

WEZEFARMA (Private Limited) - Rotselaar - BE0466775480

Dossier WEZEFARMA, printed on 30 October 2026 from databakkes.be/en/0466775480/wezefarma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

WEZEFARMA from Rotselaar, company number BE0466775480, closed financial year 2025 with a result of € 186,315 after tax. For that financial year WEZEFARMA recorded a gross margin of € 401,976 and equity of € 373,891. Compared with financial year 2024, the result moved from € 162,418 to € 186,315. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 8, 2025.

What it is worth Healthy

€ 373,891

▼ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 186,315

▲ 15% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 255,805

▲ 56% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 190,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 153,322

▲ 3% vs 2024

€ 76,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 320,550

▼ 17% vs 2024

€ 72,335 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 111,256

▲ 6% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 10,576

▲ 2% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 285,945 Gross margin 2022: € 285,945 First fiscal year in the series	€ 333,183 Gross margin 2023: € 333,183 ▲ 17% vs 2022 (€ 285,945) Favourable step	€ 368,730 Gross margin 2024: € 368,730 ▲ 11% vs 2023 (€ 333,183) Favourable step	€ 401,976 Gross margin 2025: € 401,976 ▲ 9% vs 2024 (€ 368,730) Favourable step	▲ 9%
Profit after taxes	€ 113,824 Profit after taxes 2022: € 113,824 First fiscal year in the series	€ 144,085 Profit after taxes 2023: € 144,085 ▲ 27% vs 2022 (€ 113,824) Favourable step	€ 162,418 Profit after taxes 2024: € 162,418 ▲ 13% vs 2023 (€ 144,085) Favourable step	€ 186,315 Profit after taxes 2025: € 186,315 ▲ 15% vs 2024 (€ 162,418) Favourable step	▲ 15%
Equity	€ 373,072 Equity 2022: € 373,072 First fiscal year in the series	€ 380,158 Equity 2023: € 380,158 ▲ 2% vs 2022 (€ 373,072) Favourable step	€ 377,576 Equity 2024: € 377,576 ▼ 1% vs 2023 (€ 380,158) Unfavourable step	€ 373,891 Equity 2025: € 373,891 ▼ 1% vs 2024 (€ 377,576) Unfavourable step	▼ 1%
Total debts	€ 699,479 Total debts 2022: € 699,479 First fiscal year in the series	€ 676,893 Total debts 2023: € 676,893 ▼ 3% vs 2022 (€ 699,479) Favourable step	€ 668,238 Total debts 2024: € 668,238 ▼ 1% vs 2023 (€ 676,893) Favourable step	€ 633,353 Total debts 2025: € 633,353 ▼ 5% vs 2024 (€ 668,238) Favourable step	▼ 5%
Cash	€ 194,514 Cash 2022: € 194,514 First fiscal year in the series	€ 140,609 Cash 2023: € 140,609 ▼ 28% vs 2022 (€ 194,514) Unfavourable step	€ 163,616 Cash 2024: € 163,616 ▲ 16% vs 2023 (€ 140,609) Favourable step	€ 255,805 Cash 2025: € 255,805 ▲ 56% vs 2024 (€ 163,616) Favourable step	▲ 56%
Land & buildings	€ 437,062 Land & buildings 2022: € 437,062 First fiscal year in the series	€ 424,558 Land & buildings 2023: € 424,558 ▼ 3% vs 2022 (€ 437,062) Unchanged	€ 412,054 Land & buildings 2024: € 412,054 ▼ 3% vs 2023 (€ 424,558) Unchanged	€ 399,551 Land & buildings 2025: € 399,551 ▼ 3% vs 2024 (€ 412,054) Unchanged	▼ 3%
Retained profit	€ 354,472 Retained profit 2022: € 354,472 First fiscal year in the series	€ 361,558 Retained profit 2023: € 361,558 ▲ 2% vs 2022 (€ 354,472) Favourable step	€ 358,976 Retained profit 2024: € 358,976 ▼ 1% vs 2023 (€ 361,558) Unfavourable step	€ 355,291 Retained profit 2025: € 355,291 ▼ 1% vs 2024 (€ 358,976) Unfavourable step	▼ 1%
Dividend	€ 105,000 Dividend 2022: € 105,000 First fiscal year in the series	€ 137,000 Dividend 2023: € 137,000 ▲ 30% vs 2022 (€ 105,000) Unchanged	€ 165,000 Dividend 2024: € 165,000 ▲ 20% vs 2023 (€ 137,000) Unchanged	€ 190,000 Dividend 2025: € 190,000 ▲ 15% vs 2024 (€ 165,000) Unchanged	▲ 15%
Bank debt	€ 517,279 Bank debt 2022: € 517,279 First fiscal year in the series	€ 452,282 Bank debt 2023: € 452,282 ▼ 13% vs 2022 (€ 517,279) Favourable step	€ 386,708 Bank debt 2024: € 386,708 ▼ 14% vs 2023 (€ 452,282) Favourable step	€ 320,550 Bank debt 2025: € 320,550 ▼ 17% vs 2024 (€ 386,708) Favourable step	▼ 17%
Balance sheet total	€ 1,072,551 Balance sheet total 2022: € 1,072,551 First fiscal year in the series	€ 1,057,050 Balance sheet total 2023: € 1,057,050 ▼ 1% vs 2022 (€ 1,072,551) Unchanged	€ 1,045,814 Balance sheet total 2024: € 1,045,814 ▼ 1% vs 2023 (€ 1,057,050) Unchanged	€ 1,007,244 Balance sheet total 2025: € 1,007,244 ▼ 4% vs 2024 (€ 1,045,814) Unchanged	▼ 4%
Employees (FTE)	1.6 Employees (FTE) 2022: 1.6 First fiscal year in the series	1.9 Employees (FTE) 2023: 1.9 ▲ 0.3 vs 2022 (1.6) Unchanged	2 Employees (FTE) 2024: 2 ▲ 0.1 vs 2023 (1.9) Unchanged	2 Employees (FTE) 2025: 2 Unchanged (2) Unchanged

Key figures of WEZEFARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to WEZEFARMA?

What happened at WEZEFARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Dec 8, 2025 New annual accounts for financial year 2025: profit of € 186,315 (▲ 15% vs 2024). Source: NBB ↗
2019 PASSIFLORA became a director. NBB
May 18, 2000 New establishment in Rotselaar. KBO
Sep 1, 1999 Start of the company according to the CBE. KBO

In short

From € 113,824 profit in 2022 to € 186,315 profit in 2025.

Paid € 239 in corporate taxes since 2022.

Best year ever: 2025, with € 186,315 profit.

On average € 201,000 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

PASSIFLORA 99.5%

The stake of PASSIFLORA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

WEZEFARMA

Behind WEZEFARMA is PASSIFLORA. The shares are held by PASSIFLORA (99.5%).

Directors

According to the 2025 annual accounts

PASSIFLORA

Director · represented by Barbara Vanden Brande

since 2019

Shareholders

PASSIFLORA

99.5%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Aarschotsesteenweg 154 box 0.02

3111 Rotselaar

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS wezefarma.be

Canonical: https://www.wezefarma.be/

About

Technologies

Amazon CloudFrontFont AwesomeJavaNginxPWAjQuery

Hosting & Email

Email provider

Self-hosted

Hosting

AMAZON-AES - Amazon.com, Inc., US

Website info

HTTPS Ja

Languages NL

Features

Blog Contact page

Security

✓ HTTPS

✗ SPF

✗ DMARC

Network

✓ Load balancing

Details

Company number

0466.775.480

VAT number

BE 0466.775.480

Registered office

Aarschotsesteenweg 154 bus 0.02, 3111 Rotselaar

Names & denominations

WEZEFARMA

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

1 September 1999

Peppol

Active · Active since 30 Oct 2023

Contact

wezefarma.be [email protected] 016/582292

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

WEZEFARMA

Financials

What happened to WEZEFARMA?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Website

Technologies

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions